Sincalide
In the US, Sincalide (sincalide systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Barium Meal Transit, Gallbladder Contraction and Pancreatic Secretion.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
V04CC03
CAS registry number (Chemical Abstracts Service)
0025126-32-3
Chemical Formula
C49-H62-N10-O16-S3
Molecular Weight
1143
Therapeutic Category
Diagnostic agent: Gall-bladder function
Chemical Name
Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-
Foreign Names
- Sincalidum (Latin)
- Sincalid (German)
- Sincalide (French)
- Sincalida (Spanish)
Generic Names
- Sincalide (OS: BAN, USAN)
- CCK 8 (IS)
- SQ 19844 (IS: Squibb)
- Sincalide for Injection (PH: USP 34)
Brand Name
- Kinevac
Bracco, United States
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
